Table 7.
Bone microarchitecture, failure load, and stiffness of the participants according to the presence of type 2 diabetes mellitus
| No type 2 diabetes mellitus (n = 71) | Type 2 diabetes mellitus (n = 42) | P-value | |
|---|---|---|---|
| Tibia | |||
| Total area (mm2) | 875.9 ± 164.8 | 8 897.5 ± 139.3 | 0.67 |
| Total vBMD (mg HA/cm3) | 341.7 ± 51.4 | 321.8 ± 48.9 | 0.16 |
| Tb. vBMD (mg HA/cm3) | 192.1 ± 45. | 4 176.8 ± 33.4 | 0.06 |
| Tb. Th (mm) | 0.26 ± 0.02 | 0.26 ± 0.02 | 0.83 |
| Tb. Sp (mm) | 0.62 ± 0.10 | 0.65 ± 0.10 | 0.03 |
| Ct. vBMD (mg HA/cm3) | 890.7 ± 48.5 | 900.3 ± 51.9 | 0.75 |
| Ct. Pm (mm) | 115.7 ± 11.4 | 118.1 ± 10.2 | 0.96 |
| Ct. Th (mm) | 1.92 ± 0.3 | 1.87 ± 0.4 | 0.93 |
| Ct. Po | 0.03 ± 0.01 | 0.03 ± 0.02 | 0.90 |
| F.load (kN) | 14.29 ± 2.25 | 13.61 ± 2.26 | 0.04 |
| Stiffness (kN/mm) | 265.0 ± 44.73 | 251.43 ± 43.93 | 0.04 |
| Radius | |||
| Total area (mm2) | 404.4 ± 73.9 | 400.1 ± 67.2 | 0.10 |
| Total vBMD (mg HA/cm3) | 326.4 ± 58.1 | 315.6 ± 49.7 | 0.43 |
| Tb. vBMD (mg HA/cm3) | 185.9 ± 37.0 | 175.8 ± 33.7 | 0.08 |
| Tb. Th (mm) | 0.24 ± 0.02 | 0.24 ± 0.02 | 0.27 |
| Tb. Sp (mm) | 0.58 ± 0.08 | 0.61 ± 0.10 | 0.04 |
| Ct. vBMD (mg HA/cm3) | 872.7 ± 48.2 | 872.2 ± 53.6 | 0.65 |
| Ct. Pm (mm) | 86.5 ± 8.1 | 86.1 ± 8.8 | 0.28 |
| Ct. Th (mm) | 1.15 ± 0.2 | 1.11 ± 0.2 | 0.34 |
| Ct. Po | 0.01 ± 0.005 | 0.01 ± 0.005 | 0.13 |
| F.load (kN) | 5.24 ± 1.22 | 4.98 ± 1.10 | 0.10 |
| Stiffness (kN/mm) | 96.72 ± 22.74 | 91.80 ± 20.06 | 0.09 |
Analysis of covariance. Results are presented as mean ± SD. P-value adjusted for age, free testosterone (nmol) and free estradiol (pmol).
Abbreviations: Ct., cortical; f.load, failure load; MHO, metabolically healthy obese; MUHO, metabolically unhealthy obese; Pm, perimeter; Po, porosity; Sp, spacing; Th, thickness; Tb., trabecular; vBMD, volumetric bone mineral density.